Here, we established a combined CEP and TRAIL treatment to influence apoptosis in TRAIL-resistant renal carcinoma, hepatocellular carcinoma, and lung carcinoma cells, but not in normal cells. This evidence concerns the gene TNFSF10 and hepatocellular carcinoma.